BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction: the BENEFIT-AMI Multicenter Prospective Registry
Shanghai 10th People's Hospital
774 participants
Oct 1, 2020
OBSERVATIONAL
Conditions
Summary
To validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively designed hospital-based registry. To characterize those factors that contribute to the progression of post-MI NOAF burden. To establish a prediction model for the risk stratification of patients with NOAF complicating AMI. To explore the clinical usefulness of NOAF burden in guiding the anticoagulation therapy among patients with post-MI NOAF.
Eligibility
Inclusion Criteria4
- Adult patients (\>18 years old);
- Patient with AMI (including STEMI and NSTEMI) who developed NOAF during the index hospitalization;
- Patients must have received in-hospital CEM for at least 5 days;
- Patients must give informed consent.
Exclusion Criteria8
- Patients with a medical history of pre-existing AF;
- Patients with a medical history of rheumatic valvular disease;
- Patients with a medical history of sick sinus syndrome;
- Patients undergoing emergent coronary artery bypass surgery;
- Patients who suffer malignant tumors with an expected lifetime less than 1 year ;
- Patients who refuse to receive CEM during hospitalization and the data of heart rhythm cannot be retrieved;
- Patients who refuse to receive percutaneous coronary intervention (PCI) or have contraindications for PCI;
- Patients who have died during the index hospitalization.
Interventions
All patients with NOAF complicating AMI will receive at least 5 days electronic monitoring for the evaluation of NOAF burden
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04528511